Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

505
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
505
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

1.5K
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.5K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

4.7K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.7K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

73.5K
Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
73.5K
Teratogenicity01:07

Teratogenicity

4.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline Neuroinflammation Stratifies TSPO-PET Response to Disease-Modifying Therapy in Multiple Sclerosis.

Annals of clinical and translational neurology·2026
Same author

The test-retest reproducibility of [<sup>11</sup>C]PK11195 positron emission tomography using Biograph Vision Quadra scanner.

EJNMMI research·2026
Same author

TSPO-PET-measurable neuroinflammation associates with information processing speed decline in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study.

Lancet (London, England)·2026
Same author

Association between post-COVID-19 neuropsychiatric symptoms and persistent glial activation in the limbic system: a TSPO PET study.

Journal of neurology·2026
Same author

TSPO-PET-measurable neuroinflammation associates with brain atrophy in multiple sclerosis.

Multiple sclerosis and related disorders·2026
Same journal

Anti-GAD antibody-associated epilepsy in pregnancy.

Obstetric medicine·2026
Same journal

Eplerenone in pregnancy.

Obstetric medicine·2026
Same journal

Postpartum therapeutic anticoagulation and uterine wall haematoma: A case report.

Obstetric medicine·2026
Same journal

The prevalence of the common LCHAD c.1528G>C p.(Glu510Gln) pathogenic variant in women diagnosed with acute fatty liver of pregnancy.

Obstetric medicine·2026
Same journal

Renal tubular acidosis (RTA) complicated pregnancies: A tertiary centre experience.

Obstetric medicine·2026
Same journal

A woman with homozygous familial hypercholesterolaemia requiring lipoprotein apheresis and coronary artery bypass graft in pregnancy.

Obstetric medicine·2026
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.6K

Pregnancy and multiple sclerosis.

Laura Airas1, Risto Kaaja2

  • 1Department of Neurology, Turku University Hospital , PO Box 52, 20521 Turku.

Obstetric Medicine
|September 2, 2016
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis (MS) relapse rates decrease during pregnancy but rise postpartum. This increase is linked to hormonal changes and the loss of pregnancy-induced immune suppression.

Keywords:
immunosuppressionmultiple sclerosispregnancy

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.0K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.1K

Related Experiment Videos

Last Updated: Mar 15, 2026

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.6K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.0K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.1K

Area of Science:

  • Neurology
  • Immunology
  • Reproductive Medicine

Background:

  • Multiple sclerosis (MS) relapse rates typically decrease in late pregnancy.
  • Postpartum period is associated with increased MS disease activity.
  • Pregnancy's immunosuppressive state and hormonal shifts are implicated.

Purpose of the Study:

  • To explore the reasons behind increased postpartum multiple sclerosis activity.
  • To investigate the role of hormonal changes and immune status.
  • To understand the impact of pregnancy on MS course and outcome.

Main Methods:

  • Literature review on pregnancy and multiple sclerosis.
  • Analysis of hormonal and immunological changes during postpartum.
  • Review of clinical outcomes in pregnant MS patients.

Main Results:

  • MS relapse rates decline during pregnancy.
  • Postpartum MS activity shows a significant increase.
  • Estrogen level drop and loss of immunosuppression are key factors.

Conclusions:

  • Postpartum period represents a vulnerable phase for women with MS.
  • Hormonal fluctuations and immune system recalibration drive postpartum MS flares.
  • MS generally does not negatively impact pregnancy course or outcome.